相关实验视频
Updated: Jul 12, 2025

08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.0K
描述患有晚期癌症的代表性不足的女性的自我倡导
Sarah Bell1, Rachel Bergeron2, Patricia Jo Murray2
1University of Pittsburgh Medical Center Magee-Womens Hospital.
Oncology nursing forum
|October 24, 2023
概括
来自代表性不足群体的晚期癌症妇女发展出独特的自我倡导技能. 随着时间的推移,他们学会沟通需求并有效地管理医疗保健团队.
科学领域:
- 在瘤学瘤学.
- 定性研究是指质量研究.
- 健康差异 在健康上的差异
背景情况:
- 对于患有晚期癌症的患者来说,自我辩护至关重要.
- 代表性不足的群体在癌症护理方面面临着独特的挑战.
研究的目的:
- 探索来自代表性不足的群体中患有晚期乳腺癌或妇科癌症的女性的自我倡导经验.
- 了解这些女性如何驾她们的癌症之旅.
主要方法:
- 描述性,纵向性,定性研究.
- 与10名参与者进行了一对一的采访.
- 在诊断后三个月内收集的数据.
主要成果:
- 出现了三个关键主题:发声,与医疗保健团队互动,寻求支持.
- 参与者学会了沟通他们的需求和管理他们的护理.
- 参与者的平均年龄为60.2岁.
结论:
- 来自代表性不足的群体的女性制定了独特的自我宣传策略.
- 有效的沟通和团队管理对于这些患者至关重要.
- 调查结果可以为定制的自我倡导干预措施的开发提供信息.
相关概念视频
Nursing Ethical Principles II
993
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
993
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

